Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion type Assertion NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_head.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion description "[Furthermore, PDGFRA and HRAS mRNA levels were significantly associated with tumor aggressiveness in lymph node-negative patients who had not received adjuvant systemic therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_provenance.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion evidence source_evidence_literature NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_provenance.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion SIO_000772 19966015 NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_provenance.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion wasDerivedFrom befree-20140225 NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_provenance.
- NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_assertion wasGeneratedBy ECO_0000203 NP719321.RARv-Y7vYMUFrAaGgL6F2Eyc9BABQGIyChZAcHM_aAQr4130_provenance.